Expanding Global Reach through Public Health Partnerships
Strides Pharma has been a trusted partner in global public health, supporting donor-funded programs and international procurement agencies with the supply of essential medicines to some of the world’s most disease-affected regions. With manufacturing anchored at our KRSG facility in India and WHO-prequalified partner site UCL in Kenya, we serve the institutional segment by delivering critical treatments across Africa, Latin America, Southeast Asia, and beyond.
As an approved supplier to leading global health organizations including the Global Fund, USAID, UNICEF, PAHO, UNDP, UNITAID, PEPFAR, GDF, and the Clinton Health Access Initiative, Strides plays a vital role in the fight against HIV/AIDS, malaria, tuberculosis, hepatitis, and other opportunistic infections. Our portfolio includes WHO-prequalified and PEPFAR-approved formulations that are further registered with national regulatory agencies, ensuring full compliance and market access.
Through longstanding partnerships with global health leaders such as the Medicines Patent Pool, Medicines for Malaria Venture, ViiV Healthcare, and Gilead Sciences, Strides contributes not just as a supplier but as a collaborator in expanding treatment access and enabling local impact. Our commitment to the institutional access market reflects our broader mission: to make trusted, life-saving medicines available where they are needed most.
